Search PubMed⌕ Search

Biomedical subjects

G Kabakci

Publications and source records attributed to G Kabakci.

24 records · Page 2Linked to original sources
PubMed1998

Increased QT dispersion in the absence of QT prolongation in patients with Behcet's disease and ventricular arrhythmias.

In Behcet's disease, prominent clinical manifestations include involvement of mucocutaneous, ocular, gastrointestinal, respiratory, neurologic, urogenital, articular and cardiovascular systems. Patients with Behcet's disease have higher incidence of ventricular arrhythmia than healthy subjects. However there is a little information about the mechanism of ventricular arrhythmias in Behcet's disease. The aim of the study was to investigate whether dispersion of ventricular repolarisation was an arrhythmogenic mechanism. QT dispersion parameters were measured in 73 Behcet patients and QT dispersion was defined as the difference between the maximum and minimum QT interval in any of the 12 leads of surface electrocardiogram. Corrected QT dispersion for heart rate was calculated by Bazett's formula. The results were compared with the data from 51 matched controls without a history of cardiac disease. We found QT dispersion was greater in Behcet patients (58+/-12 vs. 37+/-8 ms, P=0.001) as was corrected QT dispersion (81+/-14 vs. 52+/-11 ms, P=0.001). There was no significant difference in minimum or maximum QT intervals between Behcet patients and controls (P>0.05). We found a correlation between QT dispersion and grade of premature ventricular complexes (r=0.7, P=0.002). Our findings suggest that increased dispersion of repolarisation may account for the development of ventricular arrhythmias in Behcet's disease.

Adult↗
PubMed1997

Interferon-alpha does not cause significant cardiac dysfunction in patients with chronic active hepatitis.

The cardiac adverse effects of interferon (INF) treatment have been reported recently in various clinical trials of INF. In this study, the cardiac effects of recombinant INF-alpha treatment were evaluated prospectively in a group of patients with chronic active viral hepatitis (CAH). Sixteen patients with CAH type B, 14 patients with CAH type C and one patients with CAH type D were included in this study, and 4.5, 3 and 9 MU of recombinant INF-alpha-2a was administrated three times a week to these patients, respectively. The durations of treatment were 6 months for CAH type B and C, and 12 months for type D. The cardiac status of all patients was evaluated and monitored with a detailed medical history, physical examination, electrocardiography (ECG), telecardiography, echocardiography and heart rate variability tests at the beginning of the study and at the first and sixth months of INF therapy and also 6 months after ceasing the therapy. The clinical evaluation of patients before the treatment revealed that three had hypertension, one had a past medical history of myocardial infarction, one had a prosthetic mitral valve replacement and another had left hemiblock in her ECG record. No significant changes and adverse effects were detected in clinical examination and cardiovascular tests of all patients, either in pre-existing cardiovascular diseases, during therapy and after stopping the treatment. The cardiac adverse effects of INF reported in previous studies are questionable and we conclude that it can be used safely in CAH patients. Therefore, it should be kept in mind that fever and tachycardia may occur during the first and second weeks of INF therapy and patients with high risk for cardiac disease should be monitored closely in this period of treatment.

Adult↗
PubMed1997

Is there any association between dissection after successful percutaneous transluminal coronary angioplasty and late restenosis? An angiographic study.

Restenosis continues to be the most important limitation of percutaneous transluminal coronary angioplasty (PTCA). Many clinical, angiographic, and procedural variables are thought to be related to the development of restenosis. This study was aimed at investigating the effects of no dissection, minor dissections, and major dissections on the long-term outcome of lesions after successful PTCA. The study group comprised 91 patients with 100 lesions who underwent successful PTCA and in whom follow-up coronary angiography was performed at 8.8 +/- 7.2 (two to twenty-three) months after dilation. Dissections were classified according to the National Heart, Lung, and Blood Institute criteria. Restenosis was defined as more than 50% stenosis at follow-up angiography. Restenosis rates were found to be 22% in the no-dissection group (10 restenoses in 46 patients), 27% in the minor dissection group (11 restenoses in 40 patients), and 36% in the major dissection group (5 restenoses in 14 patients). The authors applied corrected Yates Chi-square test and no difference was observed in the restenosis rate between the group without any dissections and that with minor dissections (P > 0.05). However, a statistically significant difference was observed in the restenosis rate between the major dissection group and the other two groups (P < 0.05). The authors conclude that the occurrence of major dissections after successful PTCA may adversely affect the long-term outcome and may increase the restenosis rate.

Angioplasty, Balloon, Coronary↗
PubMed1997

Dobutamine thallium-201 myocardial SPECT in patients with left bundle branch block and normal coronary arteries.

UNLABELLED: Dobutamine is a positive inotropic and chronotropic agent and is being widely used as a pharmacologic stress agent in patients unable to achieve maximal dynamic exercise test. The purpose of the current study was to document the dobutamine induced false-positive septal defect in terms of its frequency and extent on 201Tl myocardial SPECT in patient with left bundle branch block (LBBB). METHODS: Twenty-five symptomatic patients with LBBB underwent dobutamine and redistribution 201Tl myocardial SPECT studies. Coronary angiographies were also performed. Only those patients with normal coronaries (n = 19) were included in the study. For each study, tomograms were divided into 19 segments, and each segment was analyzed qualitatively as to presence and type of perfusion defect (reversible or fixed). In addition, septal perfusion was scored in each patient (1 = markedly, 2 = moderately reduced, 3 = normal uptake). RESULTS: Sixteen of 19 patients (84.21%) had false-positive septal reversible perfusion defect, and the remaining 3 had normal images. Perfusion defects were confined to only the septum in 5 of 16 patients (31.25%), whereas a greater proportion of patients had septal defect extending to the contiguous myocardial areas, mainly to the anterior wall. Five of 16 patients with false-positive defects had a septal perfusion score of 1, while the remaining 11 had a score of 2. CONCLUSION: Dobutamine myocardial scintigraphy in patients with LBBB was misleading for the diagnosis of coronary artery disease, since up to 84.21% of patients had false-positive septal perfusion defects.

Adult↗
PubMed1993

Late percutaneous extraction of an intracardiac catheter fragment.

A patient was found to have a mobile catheter fragment in the right atrium incidentally during echocardiography. On further investigation, it was learned that the catheter had been inserted 9 years earlier during surgery and had probably been broken during removal. The patient did not experience any symptoms during this period. The catheter was removed percutaneously without any complications using a system similar to the loopsnare catheter.

Catheterization, Central Venous↗